Publié le Laisser un commentaire

Genes Affect Aging and Mortality Less Than Extrinsic Factors

A massive study from the University of Oxford has evaluated the relative impact of genetic and non-genetic factors on aging, mortality, and disease prevalence.

A deeper dive

The question of how strongly genes affect our longevity has been asked before, and the emerging answer is not very much [1]. Most of the variation in human lifespan seems to come from extrinsic factors, such as smoking and physical activity. However, quantifying the correlation between these myriad factors and longevity is tricky. In this new study coming from the University of Oxford and published in Nature Medicine, the researchers use the trove of data accumulated in the UK Biobank (UKB), a unique repository of various health data on hundreds of thousands of British citizens, to bring us closer to the answer.

The authors sought to quantify the relative contributions of environmental factors (the exposome) versus genetics in determining aging, disease risk, and premature mortality. “A strong argument that nongenetic environmental factors play a key role in aging and premature mortality,” the paper says, “comes from the observation that global human lifespan has increased nearly twofold during the past 200 years, while the human genome is expected to have been stable in such a short period.”

The exposome and mortality

The researchers started with a list of 164 environmental exposures recorded in the UKB. They conducted an exposome-wide analysis to identify environmental exposures (in this term’s broadest sense) associated with all-cause mortality and employed various methods of addressing causality and confounding. For instance, some factors, such as household income and the number of cars owned, are interconnected and had to be disentangled using statistical models. These associations were validated in independent replication and validation cohorts.

Most factors associated with mortality were modifiable (such as physical activity) rather than non-modifiable (such as ethnicity). Smoking predictably ended up on top of the list of detrimental factors, along with the frequency of feeling tired and various measures of deprivation, such as renting a home from the local council versus owning one.

On the opposite side, some of the most beneficial factors included high household income, being employed and educated, physical activity, and living with a partner as opposed to living alone. Each of those factors was associated with a hazard ratio of less than 0.8, meaning a 20% or more reduction in mortality risk.

Cornelia van Duijn, St Cross Professor of Epidemiology at Oxford Population Health and senior author of the paper, said, “Our research demonstrates the profound health impact of exposures that can be changed either by individuals or through policies to improve socioeconomic conditions, reduce smoking, or promote physical activity.”

Interestingly, being of any ethnic background other than White (Asian, Black, mixed, or other ethnicity) was also strongly associated with less mortality risk. This correlation has been confirmed for the UK by previous research [2] and stands in stark contrast with the US, where being Black is associated with a shorter lifespan. The possible reasons for this discrepancy include differences in the two healthcare systems, cultural factors such as diet, and self-selection (“the healthy immigrant effect”), as most non-White people in the UK are immigrants.

Connection to aging and diseases

The researchers were also able to tie these exposures to biological aging via the proteomic aging clock that they developed in an earlier study [3]. The clock has been shown to be associated with mortality, major chronic age-related diseases, multimorbidity, and aging-related phenotypes, including frailty and cognitive function.

Each exposure that was associated with both mortality and proteomic aging (in the same direction) was also linked to concurrent incidence of multiple age-related diseases, “indicating that the exposome is a potential catalyst of disease multimorbidity,” the paper says. Smoking (both current status and pack-years for former smokers) was associated with 21 out of 25 diseases included in the analysis, while household income, Townsend deprivation index, home ownership, and frequency of feeling tired were associated with 19 diseases. In other words, age-related diseases rarely come alone, and many environmental factors drive numerous diseases simultaneously.

“Studies on environmental health have tended to focus on individual exposures based on a specific hypothesis,” van Duijn said. “While this approach has seen many successes, the method has not always yielded reproducible and reliable findings. Instead, we have followed a ‘hypothesis free’ exposome approach and studied all available exposures to find the major drivers of disease and death.”

Genes are less important (exceptions apply)

While some diseases are caused by single-gene variants, most do not have such a clear genetic connection and are instead associated with polygenic risk scores. The researchers analyzed these scores for 22 major diseases to find that, on average, they were much less associated with mortality and aging than the exposome.

Most of the variation in mortality was explained by age and sex (with women having lower mortality risk). Genetics only explained less than 2% of additional variation, whereas the exposome explained an additional 17%.

While this was the case for most outcomes, there were some notable outliers. Polygenic risk explained more variation than the exposome in the incidence of dementias along with breast, prostate, and colorectal cancer. The exposome, on the other hand, was much more predictive of lung, heart, and liver diseases.

“While genes play a key role in brain conditions and some cancers, our findings highlight opportunities to mitigate the risks of chronic diseases of the lung, heart and liver which are leading causes of disability and death globally,” van Duijn said. “The early life exposures are particularly important as they show that environmental factors accelerate ageing early in life but leave ample opportunity to prevent long-lasting diseases and early death.”

Dr. Austin Argentieri, lead author of the study at Oxford Population Health and Research Fellow at Massachusetts General Hospital, said, “Our exposome approach allowed us to quantify the relative contributions of the environment and genetics to ageing, providing the most comprehensive overview to date of the environmental and lifestyle factors driving ageing and premature death. These findings underscore the potential benefits of focusing interventions on our environments, socioeconomic contexts, and behaviors for the prevention of many age-related diseases and premature death.”

Professor Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation, added, “Your income, postcode and background shouldn’t determine your chances of living a long and healthy life. But this pioneering study reinforces that this is the reality for far too many people.”

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.

Literature

[1] Ruby, J. G., Wright, K. M., Rand, K. A., Kermany, A., Noto, K., Curtis, D., … & Ball, C. (2018). Estimates of the heritability of human longevity are substantially inflated due to assortative mating. Genetics, 210(3), 1109-1124.

[2] White, C. (2021). Ethnic differences in life expectancy and mortality from selected causes in England and Wales: 2011 to 2014. Office for National Statistics.

[3] Argentieri, M. A., Xiao, S., Bennett, D., Winchester, L., Nevado-Holgado, A. J., Ghose, U., … & van Duijn, C. M. (2024). Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nature medicine, 30(9), 2450-2460.

Publié le Laisser un commentaire

Event Announcement: Longevity Science Summit

The Longevity Science Foundation (LSF) is thrilled to announce that it is organizing the Longevity Science Summit in Miami – the future hub of longevity sciences in the United States. The event will spotlight the latest advancements in healthy human longevity research and unite the local community for an evening of networking, collaboration, and celebration. With a fundraising goal of $250,000, the summit aims to support cutting-edge research projects on biological aging and chronic disease.

The event will welcome a mix of participants, including longevity enthusiasts, venture capitalists, private equity professionals, philanthropists, PhDs, MDs, students, community members, local government representatives, business owners, and ultra-high-net-worth (UHNW) individuals. Attendees can look forward to a presentation by LongeVC, panel discussions, and an exclusive interview with leading experts in the longevity sector and beyond.

With attendance limited to just 120 people, the LSF is fostering an intimate environment for high-profile engagement and innovative action. The summit presents a great opportunity to delve into this rapidly expanding field and contribute to the development of innovative, life-saving therapies.

“In addition to raising funds for high-quality fundamental research, our ambition is to position Miami as a hub for accessible longevity sciences, treatments, and care, building strong collaborations that yield tangible results for the advancement of groundbreaking research,” says Joshua C. Herring, President & CEO of the Longevity Science Foundation. “This summit serves as a catalyst, setting the stage for future growth and innovation in the field.”

The Longevity Science Summit will take place in Downtown Miami. The final venue details and agenda are currently being finalized and will be communicated to those who express interest in attending. The summit will span 6 to 7 hours, featuring opening remarks by Joshua C. Herring (the Longevity Science Foundation) and Michaeljohn Green (Miami Downtown Development Authority). Additional programming may be announced, with updates on the schedule and location shared as plans solidify.

Confirmed Speakers:

Kayla Barnes-Lentz (LYW Wellness)
Dr. Jose Antonio (International Society of Sports Nutrition)
Ella Davar, RD (Longevity Dietician, Founder of Gut-Brain Method)
Dr. James Galvin (University of Miami, Miller School of Medicine)
Dr. Ravindra Ganesh (Baptist Health Concierge Medicine)
Sergey Jakimov (LongeVC)
Dr. Richard Siow (Ageing Research at King’s College London)
Prof. Pawel Swietach (University of Oxford, Department of Physiology, Anatomy & Genetics)
Dr. Walter Neto (Serucell)

Supporting Companies and Sponsors Include:

Miami Downtown Development Authority
LongeVC
Baptist Health Concierge Medicine
Muhdo Health
Bean Intellisphere Group
Ageing Research at King’s College London (ARK)

Ambassadors and Partners:

European Society of Preventive Medicine (ESPM)
Longevity Journal
Dr. Deborah A. Finley
Demetri Kachevas

Proceeds from the event will continue to drive forward vital scientific research, exemplified by the LSF’s grant to the University of Oxford to investigate metabolic mechanisms of aging in the heart, as well as initiatives focused on female fertility, women’s health, and longevity. Attendees are encouraged to make donations either before or during the summit.

Even for those unable to attend, contributions are invaluable in supporting transformative longevity initiatives. For more information, to express interest, or to donate, please visit https://longevity.foundation/events

Join us in shaping the future of longevity research.

​​Press & Attendance

Lev Dvornik

ld@longevity.foundation

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.
Publié le Laisser un commentaire

Rejuvenation Roundup February 2025

February might be the shortest month of the year, but it still has room for plenty of research and advancements. Here’s what’s happened over the last four weeks.

Interviews

Junevity Is Silencing RNA to Treat Obesity and Diabetes: Some longevity biotech companies fit neatly into one of the big buckets we have in this field, like senolytics or cellular reprogramming. Others, such as Junevity, a small spin-out from the University of California, San Francisco, dare to walk an unbeaten path.

Advocacy and Analysis

The Underexplored Applications of Longevity Biotechnology: No other human endeavor today holds more promise than understanding and targeting aging. The molecular mechanisms that drive aging impact overall vigor, environmental stress resistance, reproductive health, and broad disease risk, and they fundamentally change what life means by radically changing our relationship to death.

Impressions from Hevolution’s Global Healthspan Summit 2025: These are some of the best talks from the largest healthspan conference in the world, which was held for the third time in Riyadh by the Hevolution Foundation.

Research Roundup

New Nanoparticles for Treating Arthritis: In the Journal of Nanobiotechnology, researchers have described a new method of delivering a long-lasting treatment, which involves the crucial FGF18 protein, into cartilage.

Early Adult Mortality Remains High in the US: Mortality among Americans aged 25-44 has risen substantially between 2011 and 2023, a new study has found, and it remains high even after having passed the COVID-related peak.

How the Yamanaka Factors Affect Female Reproduction in Rats: The authors of a recent study reported that OSKM/Yamanaka factor gene therapy in rats results in higher fertility at an older age compared to controls and allows older rats to have regular cycle.

Some Stem Cells Remain Youthful With Age: A team of scientists has discovered that some hematopoietic stem cells (HSCs) lose their ability to differentiate into useful somatic cells and that removing those bad HSCs is beneficial.

Creating a Functional Pancreas From Human Cells: In Cell Reports Medicine, researchers have described how they created a fully functional pancreas made from human cells and found it to work in mice, paving the way for a new era of organ replacement.

Mitochondrial Damage May Drive Type 2 Diabetes: A new study suggests that damaged mitochondria activate the integrated stress response, which causes pancreatic β-cells, as well as liver and fat cells, to lose their identity and malfunction. Blocking this response had benefits in mouse models.

Probiotics Slow Down Alzheimer’s Disease in Mice: A new study dives into a human-derived probiotic cocktail meant to protect against Alzheimer’s disease. The treatment improves gut health and reduces inflammation in mice.

A Potential New Target for Normal Brain Aging: In Aging Cell, researchers published their findings that using gene therapy to overexpress a synaptic promoter increases cognitive ability in ordinary, middle-aged mice.

A Key Protein for Tendon Health: Researchers publishing in Matrix Biology Plus have discovered that cochlin, a protein that decreases with age and has significant effects on the extracellular matrix, is vital for the health of tendons.

Repurposing Drugs to Lower Dementia Risk: The authors of a recent review analyzed the results of 14 studies that included 139 million people to identify patterns that connect dementia risk to commonly used medications.

Young Plasma Decreases Inflammation After Surgery in Trial: In the Journal of Translational Medicine, researchers have published the results of a randomized, controlled clinical trial demonstrating that plasma proteins from young donors have beneficial effects against inflammation in a surgical context.

A Generative, Foundational AI Model for Genetics: The Arc Institute, a nonprofit research organization, has published a manuscript on its creation of Evo 2, an AI foundation model that is capable of both understanding and building full genomes of organisms.

Receiving Care in Your Language Linked to Lower Health Risks: A new study suggests that people with hypertension who receive care in their preferred language are less likely to have a major cardiovascular event or die from any cause.

Effects of Estradiol and Progesterone on Knee Osteoarthritis: Recent research has addressed menopause-related molecular processes that impact the high prevalence of knee osteoarthritis in post-menopausal women. Restoration of female sex hormones in a post-menopausal mouse model improved joint health.

A Protein That Controls Senescent Cell Structure: Researchers publishing in Cellular Signaling have explained how the protein AP2A1 affects stress fibers that change with cellular senescence, altering how cells adhere to the extracellular matrix.

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial: In summary, this trial indicates a small protective effect of omega-3 treatment on slowing biological aging over 3 years across several clocks, with an additive protective effect of omega-3, vitamin D and exercise based on PhenoAge.

Senolytic compounds reduce epigenetic age of blood samples in vitro: Of eight tested compounds, JQ1, RG7112, nutlin-3a, and AMG232 reduced epigenetic age, indicating that this approach may be useful in drug screening for senolytic compounds.

Golgi-restored vesicular replenishment retards bone aging and empowers aging bone regeneration: Collectively, these findings provide insights into Golgi regulation in stem cell senescence and bone aging, which further highlight CA-EVs as a potential rejuvenative approach for aging bone regeneration.

Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species: These observations suggest that Top2 reduction confers a pro-longevity effect across species, possibly through a conserved mechanism, and may be a promising strategy for longevity intervention.

Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021: The countries that best maintained improvements in life expectancy after 2011 (Norway, Iceland, Belgium, Denmark, and Sweden) did so through better maintenance of reductions in mortality from cardiovascular diseases and neoplasms, underpinned by decreased exposures to major risks, possibly mitigated by government policies.

Enhanced paracrine action of FGF21 in stromal cells delays thymic aging: These findings establish that paracrine FGF21 improves thymic function and delays immune aging.

AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent: Thus, TNIK inhibition as a novel senomorphic strategy may inform future therapeutic approaches for diverse aging-related diseases.

Glibenclamide targets MDH2 to relieve aging phenotypes through metabolism-regulated epigenetic modification: This research not only identified MDH2 as a potential therapeutic target and Gli as a lead compound for anti-aging drug development, but also shed light on the intricate interplay of metabolism and epigenetic modifications in aging.

A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer’s disease: This study suggests that intermittent dasatinib and quercetin treatment is feasible and safe; data hint at potential functional benefits in older adults at risk of Alzheimer’s disease.

Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: These findings provide foundational evidence suggesting that MH-Pro supplementation may serve as a potential intervention for enhancing cognitive function through gut–brain axis pathways in the elderly population.

Restoring neuropeptide Y levels in the hypothalamus ameliorates premature aging phenotype in mice: Moreover, these results suggest that strategies that promote maintenance of hypothalamic NPY levels might be relevant to counteract aging progression and age-related deteriorations.

Circular RNA Telomerase Reverses Endothelial Senescence in Progeria: These data suggest that TERT circRNA is superior to linear TERT mRNA in reversing processes involved in senescence.

Long-term effects of s-KL treatment in wild-type mice: enhancing longevity, physical well-being, and neurological resilience: These results show the potential of elevating s-KL expression to simultaneously reduce the age-associated degeneration in multiple organs, increasing both life and health span.

Playful brains: a possible neurobiological pathway to cognitive health in aging: Engaging in exploratory social activities and stimulating the LC through social playfulness may offer a promising pathway to promote cognitive health and support healthy aging.

News Nuggets

Phoenix Aerie: The Launchpad for Longevity Pioneers: Phoenix Aerie (P//A), the first-ever co-living house specifically dedicated to enriching, uplifting, and empowering young longevity pioneers, will be launching. P//A offers a unique environment where emerging leaders live, learn, and grow together in the heart of the Bay Area.

Junevity Launches to Develop Cell Reset Therapeutics: Junevity, a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases, announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.